Glaxo Smith Kline (BIOC)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.00 Egyptian Pound

Market Cap 3,745,611,870.00 Egyptian Pound

Book Value (BVPS) 23.89 Egyptian Pound Based on: Fourth Quarter 2024

P/B Ratio 1.54 Last update: 2019-03-31

EPS 3.26 Egyptian Pound Based on: Fourth Quarter 2024

P/E Ratio 18.70 Last update: 2019-03-31

Trading Currency Egyptian Pound

Company Statistics

News

GSK Egypt posts EGP 106m consolidated profits in 9M-24 Financial Results

GSK Egypt’s net profits hike in H1-24 Financial Results

GSK Egypt turns to loss in Q1-24 Financial Results

GSK Egypt obtains shareholders’ nod for 2023 cash dividends Cash Dividends

GSK Egypt’s consolidated profits plunge to EGP 60m in 2023; dividends approved Financial Results

GSK Egypt records plunge in 9M-23 profits; sales hit EGP 1.57bn Financial Results

Market Announcements